Assertio (ASRT) stock closed 8% higher Monday after the company refuted allegations leveled by Buxton Helmsley over its accounting practices and drug Rolvedon. Read more here.
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback